Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000070858-24-000322
Filing Date
2024-11-14
Accepted
2024-11-14 11:58:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 doc1.htm SC 13G/A 84667
2 bac_poa.htm EX-99 5515
  Complete submission text file 0000070858-24-000322.txt   92276
Mailing Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255
Business Address BANK OF AMERICA CORPORATE CENTER 100 N TRYON ST CHARLOTTE NC 28255 7043868486
BANK OF AMERICA CORP /DE/ (Filed by) CIK: 0000070858 (see all company filings)

EIN.: 560906609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Subject) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-87760 | Film No.: 241459068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)